Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia

Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia (Hb<9)

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06061393

Enrollment

200

Registered

2023-09-29

Start date

2023-11-02

Completion date

2027-12-01

Last updated

2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Iron Deficiency, Pregnancy Anemia

Brief summary

The purpose of this study is to compare maternal outcomes such as increased hemoglobin need for blood transfusion and hemoglobin level before and post partum in women with hemoglobin \<9 gr/dl , treated with venofer and women treated with ferinject.

Interventions

DRUGVenofer 200 MG Per 10 ML Injection

treat anemia with venofer up to 5 doses

DRUGFerinject

ferinject 500 mg, once a week for 2 weeks

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 50 Years

Healthy volunteers

Inclusion criteria

pregnancy\>24 weeks of gestation anemia with Hb\<9 anemia with Hb\<9.5 if symptomatic anemia or previous postpartum hemorrhage

Exclusion criteria

* Allergy to one of the study's drugs * IV iron treatment in the last month * Underlying medical conditions associated with anemia, such as thalassemia Major, renal insufficiency, or spherocytosis * Twin pregnancy * non iron deficiency anemia

Design outcomes

Primary

Measure	Time frame	Description
ratio of women with Hb level >11 at delivery	at delivery	Hb level
postpartum Hb level	during 48 hours after delivery	gr/dl

Countries

Israel

Contacts

CONTACTmaya Wolf, MD

mayaw@gmc.gov.il972507887800

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026